Explore recent insider activity at Aquestive Therapeutics (NYSE:AQST), ownership trends, and what they may indicate about the company's long-term outlook, corporate alignment, and market sentiment.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut butter sandwich demonstrates consistent Tmax of 12 minutes Study results for swallowing ...

It has been over six months since my previous Aquestive Therapeutics (AQST) article, where I discussed Anaphylm's potential approval and some of the possible catalysts along the way to their FDA PDUFA ...

Aquestive Therapeutics (AQST) reported $11.87 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 10.2%. EPS of -$0.19 for the same period compares to ...